Eyal Orgad

Avangrid, Inc. (NYSE: AGR) (Avangrid), a leading sustainable energy company, and a member of the group of companies controlled by Iberdrola, S.A. (Iberdrola), announced that it has entered into a definitive agreement under which Iberdrola will acquire the remaining 18.4% of the issued and outstanding shares of common stock of Avangrid that it does not currently own for US$35.75 per share in an all-cash transaction, representing an approximate total amount of US$2.551 billion. The transaction is expected to close in the fourth quarter of 2024, subject to the satisfaction of customary closing conditions. Latham & Watkins LLP represents Avangrid in the transaction with a corporate deal team led by New York partners David Kurzweil and Eyal Orgad, with associates Sašo Kraner, Katherine Cody, and William Anderson. Advice was also provided on energy regulatory matters by Washington, D.C. partner Natasha Gianvecchio and Washington, D.C. counsel Anna Biegelsen; on employee benefits matters by Washington, D.C. partner Adam Kestenbaum and Houston counsel Krisa Benskin; and on tax matters by Chicago partner Joe Kronsnoble, with associate Dylan White.~~

May 20

1 min

Innovid Corp., a leading independent connected TV (CTV) advertising delivery and measurement platform, has announced it has become a publicly listed company trading on New York Stock Exchange (NYSE) under the new ticker symbol “CTV” following the completion of its previously announced business combination with ION Acquisition Corp 2 Ltd. (ION). Latham & Watkins LLP represented Innovid in the deSPAC transaction with an M&A team led by New York partner Eyal Orgad and New York counsel Michael Vardanian, with New York associates Hancen Yu, Mack Weber, and Adam Weber, and a capital markets team by Washington, D.C. partner Jason Licht, New York partner Marc Jaffe and London partner Joshua Kiernan, with Washington, D.C. associates Samuel Rettew, Eric Dolenti, and Thalia Garcia. Advice was also provided on tax matters by New York partner Jocelyn Noll, with New York associate Eric Kamerman; on intellectual property matters by Washington, D.C. partner Jeremy Wolsk, with Washington, D.C. associate Ryan Clore; and on benefits & compensation matters by Washington, D.C. partner Adam Kestenbaum.~~

Dec 2

1 min

MMS Holdings Inc. (MMS), a leading data-focused contract research organization (CRO), has announced that Lindsay Goldberg, a leading family and founder-focused private equity firm, has completed an investment in the Company alongside MMS Founder and CEO, Dr. Uma Sharma, who will maintain a significant ownership interest. MMS is an award-winning, global, data-focused CRO supporting pharmaceutical and biotech companies. Latham & Watkins LLP represented Lindsay Goldberg in the transaction with a corporate deal team led by New York partners Paul Kukish and Eyal Orgad, with associates William Tevlin, Jack Welch, Josh Barkow, Saem Kim, Ben Bussmann, and Victoria Cappucci. Advice was also provided on healthcare regulatory matters by Washington, D.C. partner Stuart Kurlander and Washington, D.C. counsel Nicole Liffrig Molife, with associate Margaret Rote; on FDA regulatory matters by Washington, D.C. partner Ben Haas, with associate Seth Olson; on tax matters by Bay Area partner Katharine Moir and New York partner Eric Kamerman, with associate Lukas Kutilek; on private equity finance matters by New York partner Kendra Kocovsky, with associates Danielle Bernstein and Joshua Guerra; on data privacy matters by Bay Area partner Heather Deixler, with associate Lydia Lim; on benefits and compensation matters by Washington, D.C. partner Adam Kestenbaum and Houston counsel Krisa Benskin; on real estate matters by New York partner Michelle Kelban and New York counsel Shira Bressler, with associate Yerin Yang; on intellectual property matters by New York partner Jeffrey Tochner, with associate Sebastian Moss; on antitrust matters by Washington, D.C. partner Amanda Reeves and Brussels counsel Tomas Nilsson; on foreign direct investment (FDI) matters by Hamburg counsel Jana Dammann, with associate Helena Hofmann; on environmental matters by New York counsel David Langer; and on insurance matters by Los Angeles partner Drew Levin, with associate Harrison White.~~

Jul 6

1 min

Hub International Limited (HUB), a leading global insurance brokerage, has announced that it has entered into an agreement with Leonard Green & Partners, L.P. (LGP), a Los Angeles-based private equity firm. With a current total enterprise valuation of US$23 billion, which represents the largest enterprise value to date for a private insurance broker, HUB expects to receive a substantial minority investment from funds managed by LGP. Latham & Watkins LLP represents LGP in the transaction with a corporate deal team led by New York partners John Giouroukakis and Eyal Orgad, with associate Saïd Bakir.~~

Apr 28

1 min

Alpha Tau Medical Ltd. (Alpha Tau), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and Healthcare Capital Corp. (Nasdaq: HCCC) (HCCC), a special purpose acquisition company, have announced the successful closing of the previously announced business combination (the Business Combination). The combined company will continue to be led by Alpha Tau's existing management team. Alpha Tau's ordinary shares and warrants are expected to begin trading on Tuesday, March 8, 2022, on Nasdaq under the ticker symbols "DRTS" and "DRTSW," respectively. Latham & Watkins LLP represented Alpha Tau in the deSPAC transaction with an M&A team led by New York partner Eyal Orgad and New York counsel Michael Vardanian, with New York associate Charles Shier, and a capital markets team led by London partner Joshua Kiernan and New York partner Nathan Ajiashvili, with London counsel Michael Rosenberg and New York associate Danny Shulman. Advice was provided on tax matters by Century City partner Pardis Zomorodi, with New York associate Sam Yang.~~

Mar 8

1 min